全文获取类型
收费全文 | 916篇 |
免费 | 88篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 53篇 |
妇产科学 | 15篇 |
基础医学 | 122篇 |
口腔科学 | 24篇 |
临床医学 | 108篇 |
内科学 | 272篇 |
皮肤病学 | 10篇 |
神经病学 | 121篇 |
特种医学 | 32篇 |
外科学 | 102篇 |
综合类 | 6篇 |
预防医学 | 28篇 |
眼科学 | 17篇 |
药学 | 28篇 |
肿瘤学 | 43篇 |
出版年
2024年 | 2篇 |
2023年 | 6篇 |
2022年 | 6篇 |
2021年 | 27篇 |
2020年 | 18篇 |
2019年 | 30篇 |
2018年 | 26篇 |
2017年 | 23篇 |
2016年 | 29篇 |
2015年 | 39篇 |
2014年 | 30篇 |
2013年 | 56篇 |
2012年 | 88篇 |
2011年 | 80篇 |
2010年 | 38篇 |
2009年 | 37篇 |
2008年 | 50篇 |
2007年 | 63篇 |
2006年 | 50篇 |
2005年 | 56篇 |
2004年 | 53篇 |
2003年 | 37篇 |
2002年 | 34篇 |
2001年 | 11篇 |
2000年 | 11篇 |
1999年 | 9篇 |
1998年 | 8篇 |
1997年 | 5篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1993年 | 8篇 |
1992年 | 4篇 |
1991年 | 6篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 3篇 |
1972年 | 4篇 |
1971年 | 2篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有1006条查询结果,搜索用时 15 毫秒
31.
32.
Qutaiba Agbaria Liat Hamama Hod Orkibi Belle Gabriel-Fried Tammie Ronen 《Child indicators research》2016,9(3):785-803
This study aimed to examine a multi-mediator model explaining how exposure to parent-child physical aggression may link with adolescents’ peer-directed physical aggression and their own subjective happiness, in an understudied Israeli Arab population. Mediators included hostility, anger, need to belong, and self-control. Arab adolescents from northern Israel (N?=?155; 62 % girls, aged 16-17) completed questionnaires regarding parents’ physical violence toward them, their own aggression toward peers, need to belong, happiness, positive emotions, and selfcontrol skills. (a) Parent-child physical aggression linked positively with peerdirected aggression through the mediating associations of hostility with anger; (b) parent-child physical aggression linked negatively with peer-directed aggression and happiness through the mediation of adolescents’ increased need to belong; and (c) parent-child physical aggression was not directly linked with self-control, but selfcontrol directly linked negatively with peer-directed aggression and positively with happiness. Findings highlight pathways through which parent-child physical aggression may simultaneously influence adolescents’ aggressive behavior and happiness. The mediation detected possible process variables (e.g., yearning for belonging, self-control skills, hostile thoughts, and angry feelings) that researchers and clinicians can consider in designing prevention and treatment interventions to break the inter-generational cycle of violence. 相似文献
33.
Ohad Ronen K. Thomas Robbins Kerry D. Olsen Ashok R. Shaha Gregory W. Randolph Iain J. Nixon Mark E. Zafereo Dana M. Hartl Luiz P. Kowalski Juan P. Rodrigo Andrs Coca‐Pelaz Antti A. Mkitie Vincent Vander Poorten Alvaro Sanabria Peter Angelos Alessandra Rinaldo Alfio Ferlito 《Head & neck》2020,42(10):3061-3071
Recent modifications in the management of well‐differentiated thyroid cancer have resulted in significant alterations in clinical approach. Utilizing a series of preoperative and postoperative risk factors involving both the patient and the disease pathology, we offer the term “staged thyroidectomy” to help organize these risk factors for patients and the endocrine team to optimize management. This approach is intended to incorporate our latest nuanced understanding of certain endocrine pathology and may serve to optimize patient outcomes. 相似文献
34.
35.
Hadar Ben-Zaken Reut Kraitman Shunit Coppenhagen-Glazer Leron Khalifa Sivan Alkalay-Oren Daniel Gelman Gilad Ben-Gal Nurit Beyth Ronen Hazan 《Viruses》2021,13(5)
Streptococcus mutans is a key bacterium in dental caries, one of the most prevalent chronic infectious diseases. Conventional treatment fails to specifically target the pathogenic bacteria, while tending to eradicate commensal bacteria. Thus, caries remains one of the most common and challenging diseases. Phage therapy, which involves the use of bacterial viruses as anti-bacterial agents, has been gaining interest worldwide. Nevertheless, to date, only a few phages have been isolated against S. mutans. In this study, we describe the isolation and characterization of a new S. mutans phage, termed SMHBZ8, from hundreds of human saliva samples that were collected, filtered, and screened. The SMHBZ8 genome was sequenced and analyzed, visualized by TEM, and its antibacterial properties were evaluated in various states. In addition, we tested the lytic efficacy of SMHBZ8 against S. mutans in a human cariogenic dentin model. The isolation and characterization of SMHBZ8 may be the first step towards developing a potential phage therapy for dental caries. 相似文献
36.
Zaza Iakobishvili Tal Hasin Robert Klempfner Nir Shlomo Ilan Goldenberg Ronen Brenner Ran Kornowski Yariv Gerber 《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1171-1179
ObjectiveTo evaluate the association between bezafibrate, a drug used to treat hypertriglyceridemia, and long-term cancer incidence in patients with coronary artery disease (CAD).Patients and MethodsThe study comprised 2980 patients with CAD (mean age, 60 years; 2729 [91.6%] men) who were free of cancer and were enrolled in the Bezafibrate Infarction Prevention study, a double-blind trial conducted between May 1, 1990, and January 31, 1993, in 18 cardiology departments in Israel. Patients randomized to receive 400 mg of bezafibrate (n=1486) or placebo (n=1494) daily for a median of 6.2 years (range, 4.7-7.6 years) were followed up for incidence of cancer through the Israeli National Cancer Registry and all-cause death through the Population Registry of the State of Israel until December 31, 2013. Cox proportional hazards and Fine and Gray survival models were used to assess the bezafibrate-cancer association.ResultsClinical characteristics and laboratory values were well balanced between the 2 groups at the study entry. Over a median follow-up of 22.5 years (range, 21.2-23.9 years), cancer developed in 753 patients. With death considered a competing event, the cumulative incidence of cancer at the end of the follow-up was lower in the bezafibrate vs the placebo group (23.9%; 95 CI, 21.9%-26.1% vs 27.2%; 95 CI, 25.1%-29.4%; P=.04). The hazard ratio for cancer in the bezafibrate vs placebo groups was 0.86 (95% CI, 0.74-0.99). In mediation analysis, the association between bezafibrate treatment and cancer incidence was not sensitive to adjustment for on-trial lipid levels but was attenuated on adjustment for on-trial fibrinogen levels.ConclusionBezafibrate treatment is associated with reduced risk of cancer among patients with CAD. Fibrinogen, but not lipid lowering, is linked to this association. 相似文献
37.
38.
Jack J. Wazen Carmelo Ortega Ronen Nazarian Joshua Smith Jack Thompson Linda Lange 《American journal of otolaryngology》2021,42(3):102864
PurposeProvide data to support expansion of FDA indications for the Bone anchored hearing system (BAHS).Materials and methodsThis retrospective study in a tertiary otologic referral center included106 consecutive subjects who were implanted with a Bone Anchored Hearing System (BAHS) between January 2009 and January 2015 for single sided deafness. Subjects were divided into three groups by bone conduction pure tone average (PTA) of the better hearing ear: 0–20 dB (group 1), 21–40 dB (group 2) and 41–55 dB (group 3). All patients underwent BAHS implantation. Speech perception data (Hearing In Noise Test and Consonant-Nucleus-Consonant testing) was collected before and after surgical intervention. Patient-reported quality of life measures were obtained at least 6 months after activation. These included the Abbreviated Profile of Hearing Aid Benefit and Glasgow Benefit Inventory.ResultsAll three groups of subjects demonstrated statistically significant improvement in outcome measures following BAHS. Subject reported quality of life outcome measures demonstrated significant improvement in disability from hearing loss and in quality of life.ConclusionsPatients with single sided deafness who have bone conduction thresholds worse than 20 dB in their contralateral ear are still able to benefit significantly from BAHS. 相似文献
39.
Shaye Kivity Yaron Zafrir Ronen Loebstein Rachel Pauzner Meir Mouallem Haim Mayan 《Autoimmunity reviews》2014,13(11):1109-1113
Objective
Low dose (10–25 mg/week) methotrexate is widely used for the management of systemic inflammatory diseases, and is considered to be relatively safe. Toxicity due to low dose MTX has been reported but is poorly characterized. We describe the clinical features, risk factors, and outcomes of low dose MTX toxicity in a large case series at our center.Patients and methods
We conducted a retrospective case series of all adult (> 18 years) patients hospitalized at Sheba Medical Center, between 2005 and 2012 for low dose MTX toxicity.Results
We identified 28 patients (age: 70.4 ± 13.7 years, range: 33–88; 20 (71%) females) hospitalized for low dose MTX toxicity. Indications for MTX therapy included: rheumatoid arthritis (39.2%), psoriasis ± arthritis (21.5%), polymyalgia rheumatica (10.8%) and other inflammatory conditions (28.5%). Pancytopenia was the most common manifestation of low dose MTX toxicity detected in 78.5% of the patients. Potential risk factors included acute renal failure, hypoalbuminemia, concurrent use of drugs known to interact with MTX, and dose errors. Serum MTX concentrations (n = 20, mean 0.04 ± 0.07 μg/mL range: 0–0.3) did not correlate with the degree of either neutropenia (r = − 0.36; p = 0.18) or thrombocytopenia (r = 0.44; p = 0.10). Seven (25%) patients died, all from pancytopenia followed by sepsis. Serum MTX concentrations did not differ between the patients who died from MTX toxicity (n = 6; mean: 0.05 ± 0.04 μg/mL) and those who survived the toxicity (n = 14 mean 0.04 ± 0.08; p = 0.45).Conclusions
Low-dose MTX toxicity can be life threatening, mainly due to myelosuppression. There is no rationale for MTX therapeutic drug monitoring in the setting of low-dose toxicity. 相似文献40.